| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 7.26B | 7.43B | 8.16B | 7.95B | 6.89B | 5.99B |
| Gross Profit | 1.85B | 1.79B | 1.75B | 1.49B | 1.33B | 1.27B |
| EBITDA | 1.18B | 1.18B | 1.17B | 982.00M | 542.00M | 800.00M |
| Net Income | 659.00M | 647.00M | 643.00M | 492.00M | 117.00M | 348.00M |
Balance Sheet | ||||||
| Total Assets | 7.83B | 7.44B | 7.64B | 7.56B | 7.00B | 6.86B |
| Cash, Cash Equivalents and Short-Term Investments | 921.00M | 1.01B | 409.00M | 239.00M | 332.00M | 665.00M |
| Total Debt | 1.80B | 2.04B | 2.40B | 2.68B | 2.25B | 2.37B |
| Total Liabilities | 3.57B | 3.55B | 3.99B | 4.30B | 3.77B | 3.79B |
| Stockholders Equity | 4.24B | 3.86B | 3.59B | 3.19B | 3.14B | 2.98B |
Cash Flow | ||||||
| Free Cash Flow | 844.00M | 1.14B | 741.00M | -148.00M | 92.00M | 489.00M |
| Operating Cash Flow | 975.00M | 1.44B | 1.06B | 152.00M | 392.00M | 829.00M |
| Investing Cash Flow | -428.00M | -47.00M | -329.00M | -320.00M | -335.00M | -571.00M |
| Financing Cash Flow | -504.00M | -765.00M | -569.00M | 103.00M | -373.00M | 143.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
73 Outperform | $9.14B | 7.46 | 31.76% | ― | 1.81% | 24.67% | |
69 Neutral | $1.78B | 28.27 | 6.82% | 3.53% | 0.54% | -24.42% | |
69 Neutral | $6.06B | 57.33 | 2.33% | ― | -0.83% | -58.55% | |
65 Neutral | $7.17B | 11.32 | 16.10% | 2.86% | -3.83% | -2.04% | |
64 Neutral | $5.08B | 17.95 | 8.56% | ― | 2.97% | -2.68% | |
62 Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% |
On November 3, 2025, Ingredion‘s Board of Directors terminated its existing stock repurchase program and approved a new one, allowing the purchase of up to 8 million shares from November 4, 2025, through December 31, 2028. This move provides the company with flexibility in managing its capital structure, although it is not obligated to repurchase any shares and can modify the program at any time.
The most recent analyst rating on (INGR) stock is a Buy with a $168.00 price target. To see the full list of analyst forecasts on Ingredion stock, see the INGR Stock Forecast page.